Introduction Executive Summary Central Nervous System Lymphoma: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Late Stage Products (Phase III) • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis F520: Shandong New Time Pharmaceutical • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early stage products (Phase I) • Comparative Analysis PRT811: Prelude Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Central Nervous System Lymphoma Key Companies Central Nervous System Lymphoma Key Products Central Nervous System Lymphoma- Unmet Needs Central Nervous System Lymphoma- Market Drivers and Barriers Central Nervous System Lymphoma- Future Perspectives and Conclusion Central Nervous System Lymphoma Analyst Views Central Nervous System Lymphoma Key Companies Appendix

Table 1 Total Products for Central Nervous System Lymphoma Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Shandong New Time Pharmaceutical • PIQUR Therapeutics • Ono Pharmaceutical • Janssen, LP • Kazia Therapeutics • Beijing InnoCare Pharma Tech • Celltrion • Bristol Myers Squibb • AstraZeneca • Novartis • Prelude Therapeutics • Kite, A Gilead Company • Celgene